{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T08:58:27Z","timestamp":1762505907388},"reference-count":33,"publisher":"Cambridge University Press (CUP)","issue":"6","license":[{"start":{"date-parts":[[2012,3,30]],"date-time":"2012-03-30T00:00:00Z","timestamp":1333065600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/www.cambridge.org\/core\/terms"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Laryngol. Otol."],"published-print":{"date-parts":[[2012,6]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Ototoxic drugs are widely used in the developing world, without audiological monitoring. Epidemiological data on ototoxic deafness are lacking for developing countries. The public health aspect of ototoxicity is often overlooked, to the detriment of the individual patient. This paper reviews ototoxic hearing loss, particularly in sub-Saharan Africa, and also assesses the impact of treatments for tuberculosis, cancer and human immunodeficiency virus (the latter including highly active antiretroviral therapy) on ototoxic hearing loss. The paper also discusses obstacles to audiological monitoring for ototoxicity in the developing world, and the potential of audiology screening using applications for mobile devices.<\/jats:p>","DOI":"10.1017\/s0022215112000357","type":"journal-article","created":{"date-parts":[[2012,3,30]],"date-time":"2012-03-30T09:44:05Z","timestamp":1333100645000},"page":"548-551","source":"Crossref","is-referenced-by-count":28,"title":["Audiological monitoring for ototoxic tuberculosis, human immunodeficiency virus and cancer therapies in a developing world setting"],"prefix":"10.1017","volume":"126","author":[{"given":"T","family":"Harris","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Peer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J J","family":"Fagan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"56","published-online":{"date-parts":[[2012,3,30]]},"reference":[{"key":"S0022215112000357_ref29","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-11-0777"},{"key":"S0022215112000357_ref32","volume-title":"Draft Report. Modernisation of Audiology Services","author":"Swart","year":"2010"},{"key":"S0022215112000357_ref25","doi-asserted-by":"publisher","DOI":"10.1086\/320522"},{"key":"S0022215112000357_ref21","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1097\/00002030-200104130-00007","article-title":"Chronic hyperlactatemia in HIV-infected patients taking antiretroviral therapy","volume":"15","author":"Moore","year":"2001","journal-title":"AIDS"},{"key":"S0022215112000357_ref16","first-page":"515","article-title":"The ear in the acquired immunodeficiency syndrome: I. Temporal bone histopathologic study","volume":"15","author":"Michaels","year":"1994","journal-title":"Am J Otol"},{"key":"S0022215112000357_ref15","doi-asserted-by":"publisher","DOI":"10.1016\/S0196-0709(00)80117-9"},{"key":"S0022215112000357_ref14","doi-asserted-by":"publisher","DOI":"10.1016\/S0360-3016(01)02641-4"},{"key":"S0022215112000357_ref11","doi-asserted-by":"publisher","DOI":"10.1016\/S1359-6446(05)03552-X"},{"key":"S0022215112000357_ref6","first-page":"35","article-title":"The ear in the acquired immunodeficiency syndrome: II. Clinical and audiologic investigation","volume":"17","author":"Soucek","year":"1996","journal-title":"Am J Otol"},{"key":"S0022215112000357_ref7","doi-asserted-by":"publisher","DOI":"10.3402\/gha.v2i0.1932"},{"key":"S0022215112000357_ref10","volume-title":"Multidrug and extensively drug resistant TB (M\/XDR-TB). 2010 Report on Surveillance and Response","year":"2010"},{"key":"S0022215112000357_ref3","unstructured":"3 UNAIDS, Global Report. In: http:\/\/www.unaids.org\/en\/KnowledgeCentre\/HIVData\/EpiUpdate\/EpiUpdArchive\/2007 [30 Jul 2010]"},{"key":"S0022215112000357_ref18","doi-asserted-by":"publisher","DOI":"10.1016\/S0194-5998(95)70292-X"},{"key":"S0022215112000357_ref24","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.1997.00550160049015"},{"key":"S0022215112000357_ref2","volume-title":"Report of an Informal Consultation on Strategies for Prevention of Hearing Impairment from Ototoxic Drugs","year":"1994"},{"key":"S0022215112000357_ref28","doi-asserted-by":"publisher","DOI":"10.1016\/j.heares.2008.01.016"},{"key":"S0022215112000357_ref5","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1016\/S0030-6665(20)30889-6","article-title":"Otologic and neurotologic manifestations of acquired immunodeficiency syndrome","volume":"25","author":"Lalwani","year":"1992","journal-title":"Otolaryngol Clin North Am"},{"key":"S0022215112000357_ref9","volume-title":"Global Tuberculosis Control 2008: Surveillance, Planning, Financing","year":"2008"},{"key":"S0022215112000357_ref1","first-page":"5","article-title":"Promoting a global health agenda for permanent childhood hearing impairment","volume":"4","author":"Olusanya","year":"2007","journal-title":"Journal of Community Ear and Hearing Health"},{"key":"S0022215112000357_ref4","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2273.1992.tb01056.x"},{"key":"S0022215112000357_ref31","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkr221"},{"key":"S0022215112000357_ref23","doi-asserted-by":"publisher","DOI":"10.1089\/met.2008.0096"},{"key":"S0022215112000357_ref26","first-page":"1516","article-title":"Correspondence: prevalence of hearing loss in a cohort of HIV-infected patients","volume":"127","author":"McNaghten","year":"2001","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"S0022215112000357_ref17","doi-asserted-by":"publisher","DOI":"10.1016\/S0753-3322(97)82326-8"},{"key":"S0022215112000357_ref33","unstructured":"33DOTS-Plus for Standardised Management of Multidrug-resistant Tuberculosis in South Africa \u2013 Policy Guidelines. In: http:\/\/www.sahealthinfo.org\/tb\/mdrtbguidelines.pdf [17 November 2011]"},{"key":"S0022215112000357_ref19","doi-asserted-by":"publisher","DOI":"10.1007\/BF00839968"},{"key":"S0022215112000357_ref22","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(99)06102-4"},{"key":"S0022215112000357_ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.heares.2006.09.015"},{"key":"S0022215112000357_ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.otohns.2008.09.027"},{"key":"S0022215112000357_ref27","doi-asserted-by":"publisher","DOI":"10.4103\/0975-7406.76494"},{"key":"S0022215112000357_ref12","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1998.226"},{"key":"S0022215112000357_ref20","doi-asserted-by":"publisher","DOI":"10.1097\/00005792-198711000-00001"},{"key":"S0022215112000357_ref30","first-page":"230","volume-title":"Pharmacology and Ototoxicity for Audiologists","author":"Fausti","year":"2006"}],"container-title":["The Journal of Laryngology &amp; Otology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S0022215112000357","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,9]],"date-time":"2022-01-09T04:03:26Z","timestamp":1641701006000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cambridge.org\/core\/product\/identifier\/S0022215112000357\/type\/journal_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3,30]]},"references-count":33,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2012,6]]}},"alternative-id":["S0022215112000357"],"URL":"https:\/\/doi.org\/10.1017\/s0022215112000357","relation":{},"ISSN":["0022-2151","1748-5460"],"issn-type":[{"value":"0022-2151","type":"print"},{"value":"1748-5460","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,3,30]]}}}